|
1
|
Shao Y, Fu R, Liu H, Wang Y, Ding S, Wang
H, Li L and Shao Z: IgG autoantibody subclasses altered in
immuno-related hemocytopenia. Cell Immunol. 294:13–20. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fu R, Liu H, Wang Y, Liu H, He H, Chen J,
Wang H, Yu H, Ding K, Huang L, et al: Distinguishing immunorelated
haemocytopenia from idiopathic cytopenia of undetermined
significance (ICUS): A bone marrow abnormality mediated by
autoantibodies. Clin Exp Immunol. 177:412–418. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Y, Wang Y, Liu H, Ding K, Hao S, Shao
Y, Wang H, Chen J, Huang L, Shao Z and Fu R: Lower level of IL-35
and its reduced inhibition in Th17 cells in patients with bone
marrow mononuclear cells Coombs test-positive hemocytopenia. Mol
Med Rep. 17:2973–2981. 2018.PubMed/NCBI
|
|
4
|
Maghazachi AA: Role of chemokines in the
biology of natural killer cells. Curr Top Microbiol Immunol.
341:37–58. 2010.PubMed/NCBI
|
|
5
|
Carotta S: Targeting NK cells for
anticancer immunotherapy: Clinical and Preclinical Approaches.
Front Immunol. 7:1522016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pittari G, Filippini P, Gentilcore G,
Grivel JC and Rutella S: Revving up natural killer cells and
cytokine-induced killer cells against hematological malignancies.
Front Immunol. 6:2302015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Purdy AK and Campbell KS: Natural killer
cells and cancer: Regulation by the killer cell Ig-like receptors
(KIR). Cancer Biol Ther. 8:2211–2220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu YF, Zhang BH, Cen DY, Wei J and Chen C:
Expression of perforin in cord blood NK cells after IL-2/IL-15
stimulation and its relation with cytotoxicity. Zhongguo Shi Yan
Xue Ye Xue Za Zhi. 19:1015–1018. 2011.(In Chinese). PubMed/NCBI
|
|
9
|
Matikainen S, Paananen A, Miettinen M,
Kurimoto M, Timonen T, Julkunen I and Sareneva T: IFN-alpha and
IL-18 synergistically enhance IFN-gamma production in human NK
cells: Differential regulation of Stat4 activation and IFN-gamma
gene expression by IFN-alpha and IL-12. Eur J Immunol.
31:2236–2245. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Peng BG Liang LJ, He Q, Li J and Lu MD:
Selective expansion of human natural killer cells. Ai Zheng.
24:1287–1289. 2005.(In Chinese). PubMed/NCBI
|
|
11
|
Wang YH, Fu R, Dong SW, Liu H and Shao ZH:
Erythroblastic islands in the bone marrow of patients with
immune-related pancytopenia. PLoS One. 9:e951432014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu H, Fu R, Li L, Ding K, Wang Y, Wang H,
Zhang T, Wang G, Song J and Shao Z: Erythropoietin receptors and
IgG autoantibody expression on nucleated erythrocytes in some cases
of immuno-related pancytopenia. Clin Lab. 61:693–698. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iannello A, Débbeche O, Samarani S,
Sabbagh S, Duval M and Ahmad A: Potential role of NK cells in
future anti-tumor immunotherapies. Med Sci (Paris). 23:502–508.
2007.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vivier E, Tomasello E, Baratin M, Walzer T
and Ugolini S: Functions of natural killer cells. Nat Immunol.
9:503–510. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lünemann A, Lünemann JD and Münz C:
Regulatory NK-cell functions in inflammation and autoimmunity. Mol
Med. 15:352–358. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Forel JM, Chiche L, Thomas G, Mancini J,
Farnarier C, Cognet C, Guervilly C, Daumas A, Vély F, Xéridat F, et
al: Phenotype and functions of natural killer cells in
critically-ill septic patients. PLoS One. 7:e504462012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Farag SS, VanDeusen JB, Fehniger TA and
Caligiuri MA: Biology and clinical impact of human natural killer
cells. Int J Hematol. 78:7–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carlens S, Gilljam M, Chambers BJ, Aschan
J, Guven H, Ljunggren HG, Christensson B and Dilber MS: A new
method for in vitro expansion of cytotoxic human
CD3−CD56+ natural killer cells. Hum Immunol.
62:1092–1098. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Luhm J, Brand JM, Koritke P, Höppner M,
Kirchner H and Frohn C: Large-scale generation of natural killer
lymphocytes for clinical application. J Hematother Stem Cell Res.
11:651–657. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Klingemann HG and Martinson J: Ex vivo
expansion of natural killer cells for clinical applications.
Cytotherapy. 6:15–22. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Huang SL, Wu YF, Wei J, Bao R and
Zhou DH: Expansion of CIK/NK cells from cord blood by using
different combinations of stem cell factor, FLT3 ligand and
interleukin 2, 7, 15 in vitro. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
12:350–354. 2004.(In Chinese). PubMed/NCBI
|
|
22
|
Chen T, Liu C, Li L, Liu H, Wang T, Shao Z
and Fu R: CD56bright natural killer cells exhibit
abnormal phenotype and function in severe aplastic anemia. Int J
Lab Hematol. 41:353–363. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li XH, Ma J, Wu XX, Wang FF, Li M, Da WM,
Yu L and Gao CJ: Study on ex vivo expansion of highly purified NK
cells from human peripheral blood and changes in their function.
Zhonghua Xue Ye Xue Za Zhi. 30:404–408. 2009.(In Chinese).
PubMed/NCBI
|
|
24
|
Wang XM, Li L, Yu JP, et al: Comparison of
four kinds of NK cell in vitro expansion methods. Chin J Cancer
Biotherapy. 336–341. 2013.(In Chinese).
|
|
25
|
Hutmacher C, Gonzalo Núñez N, Liuzzi AR,
Becher B and Neri D: Targeted delivery of IL2 to the tumor stroma
potentiates the action of immune checkpoint inhibitors by
preferential activation of NK and CD8+ T cells. Cancer
Immunol Res. 7:572–583. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carson WE, Giri JG, Lindemann MJ, Linett
ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K and
Caligiuri MA: Interleukin (IL) 15 is a novel cytokine that
activates human natural killer cells via components of the IL-2
receptor. J Exp Med. 180:1395–1403. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jelenčić V, Šestan M, Kavazović I,
Lenartić M, Marinović S, Holmes TD, Prchal-Murphy M, Lisnić B, Sexl
V, Bryceson YT, et al: NK cell receptor NKG2D sets activation
threshold for the NCR1 receptor early in NK cell development. Nat
Immunol. 19:1083–1092. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sandoval-Borrego D, Moreno-Lafont MC,
Vazquez-Sanchez EA, Gutierrez-Hoya A, López-Santiago R,
Montiel-Cervantes LA, Ramírez-Saldaña M and Vela-Ojeda J:
Overexpression of CD158 and NKG2A inhibitory receptors and
underexpression of NKG2D and NKp46 activating receptors on NK cells
in acute myeloid leukemia. Arch Med Res. 47:55–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan X, Fu R, Liu H, Wang YH, Li LJ, Liu
CY, Wang HL, Shao YY, Ding K, Chen J, et al: Quantities and
function of NK cells in patients with positive BMMNC-coombs test
and cytopenia. Zhonghua Xue Ye Xue Za Zhi. 37:393–398. 2016.(In
Chinese). PubMed/NCBI
|
